1 July 2017
| Gidon Ellis, Susie Longhorn, Vimoshan Arumuham, Rebecca Dale, Sian Allen, Simon Choong, Shabbir Moochhala, Chris Laing, Daron Smith
|
URO - Endourology & Stones
The incidence and prevalence of kidney stones is increasing [1,2]. Significant recurrence rates are noted with 14% of patients experiencing a further episode at one year, 35% at five years, and 52% at 10 years [3]. Over 10% of stone...
Urolithiasis, one of the most prevalent urological conditions worldwide, significantly affects patients’ quality of life. In the United States, its lifetime prevalence is approximately 1 in 11, while global rates vary from 1% to 13%. The management of urolithiasis offers...
Khurshid Ghani and colleagues present a novel, yet all too familiar, approach to the management of patients with staghorn calculi, in the form of anatrophic nephrolithotomy - however with the aid of a robot. The aim of this study is...
Given that the pandemic has meant that cancer surgery and treatment has been postponed, what can be done for patients if their condition isn’t life-threatening?
The Masterclass comprises a combination of didactic presentations, as-live surgery presentations, and live case observation on surgical techniques, tips and tricks, and the medical management of stone patients.
The Masterclass comprises a combination of didactic presentations, as-live surgery presentations, and live case observation on surgical techniques, tips and tricks, and the medical management of stone patients.
The Masterclass comprises a combination of didactic presentations, as-live surgery presentations, and live case observation on surgical techniques, tips and tricks, and the medical management of stone patients.
The Masterclass comprises a combination of didactic presentations, as live case observation, tips and tricks, and the medical management of stone patients.
In this UROwebinar by the European School of Urology and the EAU Section of Endourology, we will critically examine the current role of percutaneous nephrolithotomy (PCNL) in modern stone management and explore how technological innovation, patient selection, surgical expertise, and outcome data are reshaping its indications.